Determinants for clinical diagnosis of hypertrophic cardiomyopathy.

[1]  M. Link,et al.  Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. , 2005, Journal of the American College of Cardiology.

[2]  B. Maron,et al.  Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study). , 2004, The American journal of cardiology.

[3]  Barry J Maron,et al.  American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G , 2003, Journal of the American College of Cardiology.

[4]  M. Link,et al.  Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy. , 2003, Circulation.

[5]  B. Maron,et al.  Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. , 2003, The New England journal of medicine.

[6]  I. Malcic,et al.  Epidemiology of cardiomyopathies in children and adolescents: a retrospective study over the last 10 years , 2002, Cardiology in the Young.

[7]  B. Maron.  Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.

[8]  P. Elliott,et al.  Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. , 2000, Journal of the American College of Cardiology.

[9]  B. Maron,et al.  Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[10]  B. Maron,et al.  Preparticipation cardiovascular screening for US collegiate student-athletes. , 2000, JAMA.

[11]  M. Link,et al.  Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[12]  Asso,et al.  Screening for hypertrophic cardiomyopathy in young athletes. , 1998, The New England journal of medicine.

[13]  B. Maron,et al.  Profile of preparticipation cardiovascular screening for high school athletes. , 1998, JAMA.

[14]  W. Mckenna,et al.  The management of hypertrophic cardiomyopathy. , 1997, The New England journal of medicine.

[15]  F O Mueller,et al.  Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. , 1996, JAMA.

[16]  B. Maron,et al.  Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. , 1995, Journal of the American College of Cardiology.

[17]  W. Williams,et al.  Hypertrophic cardiomyopathy. Clinical spectrum and treatment. , 1995, Circulation.

[18]  J. Gardin,et al.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.

[19]  B. Maron,et al.  Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study. , 1994, The American journal of cardiology.

[20]  K. Peterson,et al.  Hypertrophic cardiomyopathy and sudden death. , 1988, The New England journal of medicine.

[21]  W. Williams,et al.  Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. , 1985, Progress in cardiovascular diseases.

[22]  W. Roberts,et al.  Sudden Death in Young Athletes , 1980, Circulation.

[23]  R. Hui,et al.  Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults. , 2004, The American journal of medicine.

[24]  B. Maron.  Hypertrophic cardiomyopathy: an important global disease. , 2004, The American journal of medicine.